Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2020.06.017
Abstract: BACKGROUND Limited data are available regarding the risk for adverse clinical events with concomitant nonsteroidal anti-inflammatory drug (NSAID) treatment after myocardial infarction (MI). OBJECTIVES The aim of this study was to investigate the risk for… read more here.
Keywords: nsaid treatment; cardiovascular bleeding; risk; bleeding events ... See more keywords
Cardiovascular and Bleeding Outcomes with Anticoagulants across Kidney Disease Stages: Analysis of a National US Cohort
Sign Up to like & getrecommendations! Published in 2021 at "American Journal of Nephrology"
DOI: 10.1159/000514753
Abstract: Background: While direct oral anticoagulants (DOACs) are considered safe among patients without chronic kidney disease (CKD), the evidence is conflicting as to whether they are also safe in the CKD and end-stage kidney disease (ESKD)… read more here.
Keywords: bleeding outcomes; disease; cardiovascular bleeding; doacs ... See more keywords